Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirchia, S. M.
Right arrow Articles by Miozzo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirchia, S. M.
Right arrow Articles by Miozzo, M.
[Cancer Research 65, 2139-2146, March 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Loss of the Inactive X Chromosome and Replication of the Active X in BRCA1-Defective and Wild-type Breast Cancer Cells

Silvia M. Sirchia1, Lisetta Ramoscelli1, Francesca R. Grati1, Floriana Barbera3,4, Danila Coradini3, Franca Rossella1, Giovanni Porta5, Elena Lesma2, Anna Ruggeri6, Paolo Radice3,4, Giuseppe Simoni1 and Monica Miozzo1

1 Genetica Medica, 2 Farmacologia, Dipartimento di Medicina, Chirurgia e Odontoiatria, Università di Milano; 3 Dipartimento di Oncologia Sperimentale, Istituto Nazionale Tumori; 4 Istituto Fondazione Italiana per la Ricerca sul Cancro di Oncologia Molecolare, Milan, Italy; 5 Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università dell'Insubria, Varese, Italy; and 6 Unità di Citogenetica e Biologia Molecolare, Laboratorio TOMA, Busto Arsizio, Italy

Requests for reprints: Silvia M. Sirchia, Genetica Medica, Dipartimento di Medicina, Chirurgia e Odontoiatria, Università di Milano, via A. di Rudinì 8, 20142 Milan, Italy. Phone: 39-2-50323025; Fax: 39-2-50323026; E-mail: silvia.sirchia{at}unimi.it.

In females, X chromosome inactivation (XCI) begins with the expression of the XIST gene from the X chromosome destined to be inactivated (Xi) and the coating of XIST RNA in cis. It has recently been reported that this process is supported by the product of the BRCA1 tumor suppressor gene and that BRCA1–/– cancers show Xi chromatin structure defects, thus suggesting a role of XCI perturbation in BRCA1-mediated tumorigenesis. Using a combined genetic and epigenetic approach, we verified the occurrence of XCI in BRCA1–/– and BRCA1wt breast cancer cell lines. It was ascertained that the Xi was lost in all cancer cell lines, irrespective of the BRCA1 status and that more than one active X (Xa) was present. In addition, no epigenetic silencing of genes normally subjected to XCI was observed. We also evaluated XIST expression and found that XIST may be occasionally transcribed also from Xa. Moreover, in one of the BRCA1wt cell line the restoring of XIST expression using a histone deacetylase inhibitor, did not lead to XCI. To verify these findings in primary tumors, chromosome X behavior was investigated in a few BRCA1-associated and BRCA1–not associated primary noncultured breast carcinomas and the results mirrored those obtained in cancer cell lines.

Our findings indicate that the lack of XCI may be a frequent phenomenon in breast tumorigenesis, which occurs independently of BRCA1 status and XIST expression and is due to the loss of Xi and replication of Xa and not to the reactivation of the native Xi.

Key Words: breast cancer • X chromosome inactivation • BRCA1 • XIST • epigenetics




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. S. Silva, R. K. Rowntree, S. Mekhoubad, and J. T. Lee
X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells
PNAS, March 25, 2008; 105(12): 4820 - 4825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Vincent-Salomon, C. Ganem-Elbaz, E. Manie, V. Raynal, X. Sastre-Garau, D. Stoppa-Lyonnet, M.-H. Stern, and E. Heard
X Inactive-Specific Transcript RNA Coating and Genetic Instability of the X Chromosome in BRCA1 Breast Tumors
Cancer Res., June 1, 2007; 67(11): 5134 - 5140.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. Thakur, K. W. Rahman, J. Wu, A. Bollig, H. Biliran, X. Lin, H. Nassar, D. J. Grignon, F. H. Sarkar, and J. D. Liao
Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer
Mol. Cancer Res., February 1, 2007; 5(2): 171 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
G. J. Pageau and J. B. Lawrence
BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin
J. Cell Biol., December 4, 2006; 175(5): 693 - 701.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.